Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics Revenue

Plus Therapeutics had revenue of $1.46M in the quarter ending September 30, 2024, with 17.42% growth. This brings the company's revenue in the last twelve months to $5.73M, up 52.63% year-over-year. In the year 2023, Plus Therapeutics had annual revenue of $4.91M with 2,093.30% growth.

• Revenue (ttm): $5.73M
• Revenue Growth: +52.63%
• P/S Ratio: 1.22
• Revenue / Employee: $286,250
• Employees: 20
• Market Cap: 7.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.91M	4.69M	2,093.30%
Dec 31, 2022	224.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	303.00K	-6.70M	-95.67%
Dec 31, 2019	7.00M	4.02M	134.60%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.